Fulcrum Therapeutics, Inc. (NASDAQ:FULC) shareholders will doubtless be very grateful to see the share price up 40% in the last month. But that doesn't change the fact that the returns over the last ...
Source LinkFulcrum Therapeutics, Inc. (NASDAQ:FULC) shareholders will doubtless be very grateful to see the share price up 40% in the last month. But that doesn't change the fact that the returns over the last ...
Source Link
Comments